Venous Thromboembolism (VTE) in pregnancy

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: June 26, 2026Bookmark

Pregnancy is a hypercoagulable state with an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE).

All clotting factors increase during pregnancy, apart from factor XI and XIII. Stasis in the lower limb vessels also increases due to compression of the iliac veins by the gravid uterus.

The most common site of thrombosis in pregnancy is the left ilio-femoral vein due to anatomical compression by the right common iliac artery over the pelvic brim (May-Thurner syndrome).

DVT is most common in the post-operative period, and is 9 times more common following caesarean delivery than vaginal delivery.

Factors contributing to venous thromboembolism in pregnancy

Component of Virchow’s triadFactors
HypercoagulabilityEstrogen increases the production of fibrinogen, factor VII, IX and X. There is also resistance to protein C in the 2nd and 3rd trimester and reduced activity of protein S and Antithrombin III. The levels of fibrinolysis inhibitors also increases.
StasisCompression of the iliac veins by the gravic uterus and hypovolemia due to hyperemesis gravidarum or hemorrhage post-partum. Immobility post-partum may also contribute to stasis
Endothelial injuryEndothelial injury from pre-eclampsia, puerperal sepsis, placental abruption and even delivery itself

Risk factors for thromboembolism in pregnancy

CategoryRisk factors
Pre existing risk factorsMaternal age > 35 years, thrombophilia, obesity (> 80 kg), history of thromboembolism, severe varicose veins, smoking, malignancy
Pregnancy-related risk factorsMultiple gestation, pre-eclampsia, grand multiparity, caesarean delivery (especially emergency), damage to pelvic veins, sepsis, prolonged bed rest
Transient risk factorsDehydration, hyperemesis, sepsis, long-distance travel
  • Risk factors for Venous Thromboembolism in Pregnancy – (IPregnancy Variable Antenatal FactorS Often Indicate Low Molecular Heparin Prophylaxis)
    • Immobility
    • Parity ≥ 3
    • Varicose veins (gross)
    • Age > 35 years
    • Family history of VTE
    • Smoker
    • Obesity
    • IVF conception
    • Low-risk thrombophilia
    • Multiple pregnancies
  • Signs and symptoms of deep venous thrombosis
    • Symptoms are often unilateral
      • Pain
      • Swelling
      • Tenderness
      • Redness
    • Leg circumference discrepancy of > 3 cm in the affected leg (measured 10 cm from the ischial tuberosity or 20 cm from the ASIS)
  • Signs and symptoms of pulmonary embolism
  • Differentials
    • Cellulitis
    • Superficial thrombophlebitis (has a palpable cord)
    • Varicose veins
    • Lymphedema
    • Compartment syndrome
    • Ruptured popliteal cyst
  • Investigations
    • Doppler ultrasound of the lower limb to diagnose DVT. Repeat negative ultrasound on day 3 and 7 in high-risk patients.
    • Venography is ****a more invasive and expensive alternative to doppler ultrasound
    • Chest X-ray and EKG are the initial investigations for patients with suspected pulmonary embolism
    • CT-pulmonary angiogram (CTPA) or Ventilation-perfusion (VQ) scan for definitve diagnosis of pulmonary embolism. CTPA is preferred if there is an abnormal chest X-ray. It carres a high risk of breast cancer for the mother.
    • D-dimer is ****not useful since pregnancy causes a rise in D-dimer
    • aPTT to ensure the patient is accurate ly heparinized
      • Adequate heparinization = aPTT 1.5-2.5
  • Treatment
    • Adequate hydration
    • Limb elevation
    • Bed rest
    • Analgesia
    • Elastic stockings
    • Early ambulation post-operative
    • IV unfractionated heparin (UFH)
    • Check for adequate heparinization with aPTT
    • Switch to SC LMWH once acute phase is over
    • Thrombolysis or surgical embolicteomy for pulmonary embolism
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team